Rye Dalton

Rye Dalton is currently serving as the VP of Commercial Analytics and Operations at Neurocrine Biosciences, a position held since February 2024. Prior to this role, Rye Dalton was with Acacia Pharma Inc. for six years, first as Vice President of Commercial Analytics and Operations and then as Senior Vice President of the same department. Between April 2015 and February 2018, Rye Dalton was the Vice President of Commercial Operations at Otonomy, Inc. Previous experience includes roles at Cadence Pharmaceuticals as Sr. Director of Commercial Operations and Director of Sales Operations and Analytics, as well as positions at Amylin Pharmaceuticals, where Rye Dalton held the title of Sr. District Sales Manager and Director of Commercial Operations and Communications. Educational credentials include an MBA from Ohio University and a BA in Political Science and Economics from the University of Cincinnati.